Study Alleges Mortality Miscount in FOURIER Trial; TIMI Grou

Clinical trialists, including Marc Sabatine, as well as evolocumab’s manufacturer reject the reanalysis as flawed and sensationalistic.

Related Keywords

Spain , Canada , Boston , Massachusetts , United States , Juan Erviti , Sanofi Regeneron , Steven Nissen , Marc Sabatine , Amgen , Drug Administration , European Medicines Agency , Health Canada , Phd Navarre Health Service , Data Collection For Cardiovascular Trials Initiative , Novartis , Navarre Health Service , Restoring Invisible , Abandoned Trials , Cleveland Clinic , Hazard Ratio , Still Not , New England Journal , European Medicines , Open Label Extension , Standardized Data Collection , Cardiovascular Trials Initiative ,